Thank you for holding. Welcome to the Lexicon Pharmaceuticals' First Quarter 2013 Conference Call. At this time, all participants are in listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at Lexicon's request.
Welcome to the Lexicon Pharmaceuticals Second Quarter 2011 Conference Call. At this time all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at Lexicon s request.
After a strong runup from our recommendation, is it time to take money off the table in Lexicon Pharmaceuticals ?
The small-cap biotech firm's experimental diabetes drug could make it a M&A target says Morningstar's Karen Anderson.